Medication info
Lipitapa Tablet 1mg (Pitavastatin Calcium Hydrate)

Lipitapa Tablet 1mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›1.102mg / 1 tablet
Manufacturer / importer
Geonil Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202102776 · Approved 2021.03.30 · Insurance code 646803100

Summary

Main use
Improvement of hypercholesterolemia (including pediatric familial hypercholesterolemia) and mixed dyslipidemia
Who takes it
Adults · Children
Adult dose
Patients taking this drug before and during treatment must follow a standard cholesterol-lowering diet. 1. Adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels and increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial, Fredrickson type IIa) and mixed dyslipidemia (Fredrickson type IIb) The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this drug is maintained with continued administration.
Child dose
Ages 10 ~ 16 years: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 2 mg daily.

Ingredients

Manufacturer
Geonil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (including pediatric familial hypercholesterolemia) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B protein
  • elevated triglyceride levels
  • heterozygous familial hypercholesterolemia
  • a family history of early cardiovascular disease
  • cardiovascular disease risk factors
View approved original text

This medication is used as an adjunct to diet to lower total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while raising HDL cholesterol levels. It is effective in children aged 10 to 16 years with heterozygous familial hypercholesterolemia, significantly reducing total cholesterol and LDL cholesterol levels. It is particularly suitable for patients with high LDL cholesterol, a family history of early cardiovascular disease, or cardiovascular risk factors. This medication is utilized to improve lipid metabolism and support cardiovascular health.

How to take

Adult dose

Patients taking this drug before and during treatment must follow a standard cholesterol-lowering diet. 1. Adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels and increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial, Fredrickson type IIa) and mixed dyslipidemia (Fredrickson type IIb) The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this drug is maintained with continued administration.

Child dose

Ages 10 ~ 16 years: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 2 mg daily.

Precautions

This medication should not be used by patients with allergies to specific components or with active liver disease. Patients with severely impaired liver function or bile flow problems should also not take this medication. Patients on cyclosporine, those with myopathy, pregnant or possibly pregnant women, and nursing mothers should refrain from taking this medication. It is also not administered to patients with genetic metabolic disorders such as lactose intolerance. Patients with renal dysfunction or liver impairment should use this medication cautiously, particularly if taken in conjunction with fibrates or niacin, as the risk of muscle damage may increase. Patients consuming excessive alcohol should exercise caution when taking this medication. Elderly patients, children, those with hypothyroidism, patients with genetic muscle disorders, and those with a history of drug-related muscle damage should also be carefully administered this medication. Possible side effects include myalgia, fatigue, abnormal liver function, skin rashes, and in severe cases, rhabdomyolysis may occur. If such symptoms occur, discontinue use immediately and consult a physician. Before and during treatment, regular liver function tests should be conducted to assess liver health, and blood lipid levels should be periodically evaluated to assess treatment efficacy. This medication may interact with other drugs; therefore, caution is required when taken with cyclosporine, fibrates, niacin, and erythromycin. The risk of muscle damage or renal function deterioration may increase with concurrent use of these drugs, and it should be taken as prescribed by a physician. Elderly patients have decreased physical functions, so they need careful monitoring for potential side effects, and dosage adjustments may be necessary if adverse reactions occur. Pregnant or nursing women should not take this medication, and women who may become pregnant should consult a physician before use. In children, this medication should only be administered under strict medical supervision for the treatment of familial hypercholesterolemia, with close monitoring of activity levels and muscle condition. This medication should be kept out of the reach of children and stored in its original container for safety.

Side effects

Abdominal pain, rash, malaise, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, headache, myalgia, weakness, increased CPK levels, elevated myoglobin in blood and urine, liver dysfunction, jaundice, thrombocytopenia, urticaria, erythema, angioedema, elevated bilirubin, increased cholinesterase, elevated ALP, elevated LDH, stiffness, drowsiness, insomnia, heaviness, dizziness, dry mouth, dyspepsia, abdominal distension, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, discomfort in the stomach, diarrhea, decreased granulocytes, leukopenia, increased eosinophils, leukocytosis, elevated globulins, positive Coombs test, anemia, polyuria, elevated BUN, increased serum creatinine, decreased aldosterone, elevated aldosterone, increased adrenocorticotropic hormone, elevated cortisol, decreased testosterone, muscle cramps, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste disturbances, discolored urine, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, facial edema, arm edema, hypersensitivity, skin tingling, elevated blood pressure, chest discomfort, weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its efficacy.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.